Oral SERD Elacestrant is now an option for metastatic hormone-receptor positive breast cancer: Findings from the Phase III EMERALD Trial March 27, 2023
FDA Approves Retifanlimab-dlwr for Metastatic or Recurrent Locally Advanced Merkel Cell Carcinoma March 24, 2023
Dr. Rubina Suwal of the Binaytara Foundation Cancer Center Receives ASCO International Innovation Grant March 24, 2023